Catapano, A. L., Lautsch, D., Tokgözoglu, L., Ferrieres, J., Horack, M., Farnier, M., … Gitt, A. K. (2016). Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice. Atherosclerosis, 252, 1–8. https://doi.org/10.1016/j.atherosclerosis.2016.07.007

Catapano, Alberico L., Dominik Lautsch, Lale Tokgözoglu, Jean Ferrieres, Martin Horack, Michel Farnier, Peter P. Toth, et al. “Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice.” Atherosclerosis 252 (September 2016): 1–8. https://doi.org/10.1016/j.atherosclerosis.2016.07.007.

Catapano AL, Lautsch D, Tokgözoglu L, Ferrieres J, Horack M, Farnier M, et al. Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice. Atherosclerosis. 2016 Sep;252:1–8.

Catapano, Alberico L., et al. “Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice.” Atherosclerosis, vol. 252, Elsevier BV, Sept. 2016, pp. 1–8. Crossref, doi:10.1016/j.atherosclerosis.2016.07.007.

Catapano AL, Lautsch D, Tokgözoglu L, Ferrieres J, Horack M, Farnier M, Toth PP, Brudi P, Tomassini JE, Ambegaonkar B, Gitt AK. Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice. Atherosclerosis. Elsevier BV; 2016 Sep;252:1–8.